In situ detection of lipid peroxidation by-products in chronic liver diseases

Hepatology

Volumn 26, Issue 1, 1997, Pages 135-142

  Paradis, Valerie ^a   Kollinger, Michael ^b   Fabre, Monique ^a   Holstege, Axel ^b   Poynard, Thierry ^c   Bedossa, Pierre ^a  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; MALONALDEHYDE;

ADOLESCENT; ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; CELLULAR DISTRIBUTION; CHILD; CHRONIC LIVER DISEASE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HEMOCHROMATOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; WILSON DISEASE;

EID: 0031011220     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260118     Document Type: Article

References (35)

1. Cheeseman KH. Mechanisms and effects of lipid peroxidation. Molec Aspects Med 1993;14:191-197.
2. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad Biol Med 1992;11:81-128.
3. Poli G, Albano E, Dianzani MU. The role of lipid peroxidation in liver damage. Chem Phys Lipids 1987;45:117-142.
4. Poli G, Parola M, Leonarduzzi G, Pinzani M. Modulation of hepatic fibrogenesis by antioxidants. Molec Aspects Med 1993;14:259-264.
5. Carini R, Comoglio A, Albano E, Poli G. Lipid peroxidation and irreversible damage in the rat hepatocyte model. Biochem Pharmacol 1992;43: 2111-2115.
6. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasanthy S, Carew T, Butler S, Witzum JL. Evidence of the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086-1095.
7. Poli G. Liver damage due to free radicals. Br Med Bull 1993;49:604-620.
8. Cerutti P. Pro-oxidant states and tumor progression. Science 1985;227: 375-381.
9. Britton RS, Bacon BR. Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterol 1994;41:343-348.
10. Farinati F, Cardin R, De Maria N, Lecis PE, Della Libera G, Burra P, Marafin C, et al. Zinc, iron and peroxidation in liver tissue. Biological Trace Element Research 1995;47:193-199.
11. Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 1995;22: 449-456.
12. Parola M, Pinzani M, Casini A, Albano E, Poli G, Gentilini A, Gentilini P, et al. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen ́1 (I) gene expression in human fat-storing cells. Biochem Biophys Res Comm 1993;194:1044-1050.
13. Kamimura S, Gaal K, Britton RS, Bacon BR, Triadafilopoulos G, Tsukamoto H. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis. HEPATOLOGY 1992;16:448-453.
14. Chojkier M, Houglum K, Herruzo JS, Brenner DA. Stimulation of collagen expression by ascorbic acid in cultured human fibroblasts. J Biol Chem 1989;264:16957-16962.
15. Bedossa P, Houglum K, Trautwein C, Holstege A, Alcorn J, Chojkier M. Stimulation of collagen ́1 (I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? HEPATOLOGY 1994;19:1262-1271.
16. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Rad Biol Med 1990;9:515-540.
17. Uchida K, Szweda LI, Chae H-Z, Stadtman ER. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc Natl Acad Sci U S A 1993;90:8742-8746.
18. Palinski W, Yla-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasanthy S, Cuttiss LK, et al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density protein. Arteriosclerosis 1990;10:325-335.
19. Bedossa P, Poynard T (for the Metavir cooperative study group). An algorithm for the grading of activity in chronic hepatitis. HEPATOLOGY 1996;24:289-293.
20. Scheuer PJ. Primary biliary cirrhosis. Proc Roy Soc Med 1967;60:1257-1260.
21. Habeeb AFSA. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem 1966,14:328-336.
22. Recknagel RO, Glende EA, Dolak JA. Mechanisms of carbon tetrachloride toxicity. Pharmacol Therapy 1987;43:139-154.
23. Schuppan D. Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Semin Liver Dis 1990;10:1-10.
24. Niemelä O, Parkkila S, Ylä-Herttuala S, Halsted C, Witzum JL, Lanca A, Israel Y: Covalent protein adducts in the liver as a result of ethanol metabolism and lipid peroxidation. Lab Invest 1994;70: 537-546.
25. Holstege A, Bedossa P, Poynard T, Kollinger M, Chaput JC, Houglum K, Chojkier M. Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: localization and association with progression of liver fibrosis. HEPATOLOGY 1994; 19:367-373.
26. Jukkola A, Niemelä O. Covalent binding of acetaldehyde to type III collagen. Biochem Biophys Res Commun 1989;159:163-169.
27. Reinke LA, Lai EK, DuBose CM, McCay PB. Reactive free radical generation in vivo in heart and liver of ethanol-fed rats: correlation with radical formation in vitro. Proc Natl Acad Sci U S A 1987;84:9223-9227.
28. Mukhopadhyay CK. Free-metal ion-independent oxidative damage of collagen-protection by ascorbic acid. J Biol Chem 1994;269:30200-30205.
29. Houglum K, Filip M, Witztum, Chojkier M. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J Clin Invest 1990;86:1991-1998.
30. Tsukamoto H, Horne W, Kamimura S, Niemelä O, Parkkila S, YläHerttuala S, Brittenham GM. Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 1995;96:620-630.
31. Nordmann R. Alcohol and antioxidant systems. Alcohol Alcohol 1994; 29:513-522.
32. Tsukamoto H. Oxidative stress, antioxidants, and alcoholic liver fibrogenesis. Alcohol 1993;10:465-467.
33. Panozzo MP, Basso D, Balint L, Biasin MR, Bonvicini P, Metus P, Infantolino D, et al. Altered lipid peroxidation/glutathione ratio in experimental extrahepatic cholestasis. Clin Exp Pharmacol Physiol 1995;22: 266-271.
34. Leonarduzzi G, Parola M, Muzio G, Garramone A, Maggiora M, Robino G, Poli G, et al. Hepatocellular metabolism of 4-hydroxynonenal is impaired in conditions of chronic cholestasis. Biochem Biophys Res Comm 1995;214:669-675.
35. Schaur RJ, Dussing G, Kink E, Schauenstein E, Posch W, Kukovetz E, Egger G. The lipid peroxidation product 4-hydroxynonenal is formed by - and is able to attract - rat neutrophils in vivo. Free Rad Res Comm 1994;20:365-373.